Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8

Ignoring the sacroiliac joint in chronic low back pain is costly

Authors Polly D, Cher D

Received 29 September 2015

Accepted for publication 1 December 2015

Published 21 January 2016 Volume 2016:8 Pages 23—31

DOI https://doi.org/10.2147/CEOR.S97345

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Qian Ding

Peer reviewer comments 3

Editor who approved publication: Professor Giorgio Lorenzo Colombo

David W Polly,1,2 Daniel Cher3

1Department of Orthopedic Surgery, 2Department of Neurosurgery, University of Minnesota, Minneapolis, MN, 3SI-BONE, Inc., San Jose, CA, USA

Background: Increasing evidence supports minimally invasive sacroiliac joint (SIJ) fusion as a safe and effective treatment for SIJ dysfunction. Failure to include the SIJ in the diagnostic evaluation of low back pain could result in unnecessary health care expenses.
Design: Decision analytic cost model.
Methods: A decision analytic model calculating 2-year direct health care costs in patients with chronic low back pain considering lumbar fusion surgery was used.
Results: The strategy of including the SIJ in the preoperative diagnostic workup of chronic low back pain saves an expected US$3,100 per patient over 2 years. Cost savings were robust to reasonable ranges for costs and probabilities, such as the probability of diagnosis and the probability of successful surgical treatment.
Conclusion: Including the SIJ as part of the diagnostic strategy in preoperative patients with chronic low back pain is likely to be cost saving in the short term.

Keywords: chronic low back pain, lumbar fusion, sacroiliac joint pain, sacroiliac joint fusion, healthcare costs, decision modeling

Corrigendum for this paper has been published

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Work intensity in sacroiliac joint fusion and lumbar microdiscectomy

Frank C, Kondrashov D, Meyer SC, Dix G, Lorio M, Kovalsky D, Cher D

ClinicoEconomics and Outcomes Research 2016, 8:367-376

Published Date: 26 July 2016

Cost-effectiveness of minimally invasive sacroiliac joint fusion [Corrigendum]

Cher DJ, Frasco MA, Arnold RJG, Polly DW

ClinicoEconomics and Outcomes Research 2016, 8:305-306

Published Date: 27 June 2016

Cost-effectiveness of minimally invasive sacroiliac joint fusion

Cher DJ, Frasco MA, Arnold RJG, Polly DW

ClinicoEconomics and Outcomes Research 2016, 8:1-14

Published Date: 18 December 2015

Implant survivorship analysis after minimally invasive sacroiliac joint fusion using the iFuse Implant System®

Cher DJ, Reckling WC, Capobianco RA

Medical Devices: Evidence and Research 2015, 8:485-492

Published Date: 23 November 2015

Sacroiliac joint pain: burden of disease

Cher D, Polly D, Berven S

Medical Devices: Evidence and Research 2014, 7:73-81

Published Date: 12 April 2014

Safety and 6-month effectiveness of minimally invasive sacroiliac joint fusion: a prospective study

Duhon BS, Cher DJ, Wine KD, Lockstadt H, Kovalsky D, Soo CL

Medical Devices: Evidence and Research 2013, 6:219-229

Published Date: 13 December 2013

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

A new recombinant factor VIII: from genetics to clinical use

Santagostino E

Drug Design, Development and Therapy 2014, 8:2507-2515

Published Date: 12 December 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012